These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10088142)

  • 1. Cocaine withdrawal and the cerebral influx of [18F]fluoro-L-DOPA (FDOPA).
    Cumming P; Reith J; Gjedde A
    Neuropsychopharmacology; 1999 Apr; 20(4):395-8. PubMed ID: 10088142
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal.
    Wu JC; Bell K; Najafi A; Widmark C; Keator D; Tang C; Klein E; Bunney BG; Fallon J; Bunney WE
    Neuropsychopharmacology; 1997 Dec; 17(6):402-9. PubMed ID: 9397428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
    Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
    J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of an 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism.
    Ishiwata K; Shinoda M; Ishii S; Nozaki T; Senda M
    Nucl Med Biol; 1996 Apr; 23(3):295-301. PubMed ID: 8782240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat.
    Reith J; Dyve S; Kuwabara H; Guttman M; Diksic M; Gjedde A
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):707-19. PubMed ID: 2117017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.
    Kuwabara H; Cumming P; Reith J; Léger G; Diksic M; Evans AC; Gjedde A
    J Cereb Blood Flow Metab; 1993 Jan; 13(1):43-56. PubMed ID: 8417009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time profile of cerebral [18F]6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA.
    Endres CJ; DeJesus OT; Uno H; Doudet DJ; Nickles JR; Holden JE
    Front Biosci; 2004 Jan; 9():505-12. PubMed ID: 14766386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolites of 6-[18F]fluoro-L-dopa in human blood.
    Firnau G; Sood S; Chirakal R; Nahmias C; Garnett ES
    J Nucl Med; 1988 Mar; 29(3):363-9. PubMed ID: 3126278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier and neuronal membrane transport of 6-[18F]fluoro-L-DOPA.
    Yee RE; Cheng DW; Huang SC; Namavari M; Satyamurthy N; Barrio JR
    Biochem Pharmacol; 2001 Nov; 62(10):1409-15. PubMed ID: 11709201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and blood-brain clearance of L-3,4-dihydroxy-[3H]phenylalanine ([3H]DOPA) and 6-[18F]fluoro-L-DOPA in the rat.
    Cumming P; Ase A; Diksic M; Harrison J; Jolly D; Kuwabara H; Laliberté C; Gjedde A
    Biochem Pharmacol; 1995 Sep; 50(7):943-6. PubMed ID: 7575677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis and determination for enantiomeric purity of 6-fluoro-L-DOPA].
    Tang GH; Zhang L; Tang XL; Wang YX; Yin DZ
    Yao Xue Xue Bao; 2001 Oct; 36(10):739-42. PubMed ID: 12579971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment.
    Lizarraga KJ; Allen-Auerbach M; Czernin J; DeSalles AA; Yong WH; Phelps ME; Chen W
    J Nucl Med; 2014 Jan; 55(1):30-6. PubMed ID: 24167081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine.
    Doudet DJ; Chan GL; Jivan S; DeJesus OT; McGeer EG; English C; Ruth TJ; Holden JE
    J Cereb Blood Flow Metab; 1999 Mar; 19(3):278-87. PubMed ID: 10078880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.
    Melega WP; Grafton ST; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):890-7. PubMed ID: 1939384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
    Huang SC; Yu DC; Barrio JR; Grafton S; Melega WP; Hoffman JM; Satyamurthy N; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):898-913. PubMed ID: 1939385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No-carrier-added regioselective preparation of 6-[18F]fluoro-L-dopa.
    Lemaire C; Guillaume M; Cantineau R; Christiaens L
    J Nucl Med; 1990 Jul; 31(7):1247-51. PubMed ID: 2113943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.
    Kumakura Y; Vernaleken I; Gründer G; Bartenstein P; Gjedde A; Cumming P
    J Cereb Blood Flow Metab; 2005 Jul; 25(7):807-19. PubMed ID: 15729292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
    Cumming P; Léger GC; Kuwabara H; Gjedde A
    J Cereb Blood Flow Metab; 1993 Jul; 13(4):668-75. PubMed ID: 8314919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatic radiofluorination with [18F]fluorine gas: 6-[18F]fluoro-L-dopa.
    Firnau G; Chirakal R; Garnett ES
    J Nucl Med; 1984 Nov; 25(11):1228-33. PubMed ID: 6436449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New rapid analysis method demonstrates differences in 6-[18F] fluoro-L-dopa plasma input curves with and without carbidopa and in hemi-MPTP lesioned monkeys.
    McLellan CA; Doudet DJ; Brücke T; Aigner TG; Cohen RM
    Int J Rad Appl Instrum A; 1991; 42(9):847-54. PubMed ID: 1657833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.